Award
Delivery Order #SPE2DP26F3003
Delivery Order for Midazolam Hydrochloride from DMS Pharmaceutical Group
Buyer
Defense Logistics Agency
Award Amount
$77.66
Ceiling
$77.66
Awarded
February 23, 2026
Period of Performance
Feb 23, 2026 – Mar 10, 2026
Identifier
SPE2DP26F3003
NAICS
424210
This award is a delivery order contract issued under a long-term definitive contract with DMS Pharmaceutical Group Inc., a specialized pharmaceutical distributor. The contract focuses on procuring Midazolam Hydrochloride, a critical medication used in healthcare settings. This procurement supports federal health agencies by ensuring availability of essential pharmaceuticals, highlighting the contract's role in sustaining vital public health services. The scope of work includes the timely delivery of Midazolam Hydrochloride to meet specific agency needs within a short performance window. The award was competitively sourced under the umbrella of an existing indefinite delivery vehicle contract, reflecting a strategic and reliable supply chain management approach. Performance is scheduled over a concise period in early 2026, aligning with urgent medication demand. This award complements the broader definitive pharmaceutical supply contract held by DMS Pharmaceutical Group, which covers a diverse range of medications essential for comprehensive medical treatment.
Description
8511937626!MIDAZOLAM HYDROCHLO